Quantifying tumour hypoxia with fluorine-18 fluoroerythronitroimidazole ([18F]FETNIM) and PET using the tumour to plasma ratio
暂无分享,去创建一个
Tove Grönroos | Heikki Minn | Vesa Oikonen | Olli Eskola | V. Oikonen | H. Minn | K. Lehtiö | T. Grönroos | Anne Roivainen | A. Roivainen | O. Eskola | Kaisa Lehtiö | Samuel Nyman | S. Nyman | Samuel Nyman
[1] E. Hall,et al. Radiobiology for the radiologist , 1973 .
[2] J. Overgaard,et al. Modification of Hypoxia-Induced Radioresistance in Tumors by the Use of Oxygen and Sensitizers. , 1996, Seminars in radiation oncology.
[3] A. Nunn,et al. Nitroimidazoles and imaging hypoxia , 1995, European Journal of Nuclear Medicine.
[4] C S Patlak,et al. Graphical Evaluation of Blood-to-Brain Transfer Constants from Multiple-Time Uptake Data , 1983, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[5] J. Brown,et al. Exploiting the hypoxic cancer cell: mechanisms and therapeutic strategies. , 2000, Molecular medicine today.
[6] C. Ling,et al. On measuring hypoxia in individual tumors with radiolabeled agents. , 2001, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[7] A. J. Varghese,et al. Binding to cellular macromolecules as a possible mechanism for the cytotoxicity of misonidazole. , 1980, Cancer research.
[8] G. Hanks,et al. Single-photon emission computed tomography and positron-emission tomography assays for tissue oxygenation. , 2001, Seminars in radiation oncology.
[9] H. Minn,et al. Pharmacokinetics of [18F]FETNIM: a potential marker for PET. , 2001, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[10] G. Arteel,et al. Comparisons among pimonidazole binding, oxygen electrode measurements, and radiation response in C3H mouse tumors. , 1999, Radiation research.
[11] David J. Yang,et al. Development of F-18-labeled fluoroerythronitroimidazole as a PET agent for imaging tumor hypoxia. , 1995, Radiology.
[12] P. Sminia,et al. Effects of hyperbaric oxygen and normobaric carbogen on the radiation response of the rat rhabdomyosarcoma R1H. , 2001, International journal of radiation oncology, biology, physics.
[13] J. Overgaard,et al. Pretreatment oxygenation predicts radiation response in advanced squamous cell carcinoma of the head and neck. , 1996, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[14] J. D. Chapman,et al. Characteristics of the metabolism-induced binding of misonidazole to hypoxic mammalian cells. , 1983, Cancer research.
[15] M. Graham,et al. A modeling approach for quantifying tumor hypoxia with [F-18]fluoromisonidazole PET time-activity data. , 1995, Medical physics.
[16] J. Logan. Graphical analysis of PET data applied to reversible and irreversible tracers. , 1999, Nuclear medicine and biology.
[17] V. Oikonen,et al. Imaging of blood flow and hypoxia in head and neck cancer: initial evaluation with [(15)O]H(2)O and [(18)F]fluoroerythronitroimidazole PET. , 2001, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[18] P. Allen,et al. Nuclear magnetic resonance spectroscopy and sensitizer-adduct measurements of photodynamic therapy-induced ischemia in solid tumors. , 1991, Journal of the National Cancer Institute.
[19] J. Overgaard,et al. Invasive oxygen measurements and pimonidazole labeling in human cervix carcinoma. , 2001, International journal of radiation oncology, biology, physics.
[20] A. Giaccia,et al. The unique physiology of solid tumors: opportunities (and problems) for cancer therapy. , 1998, Cancer research.
[21] H. Minn,et al. Pharmacokinetics of [18F]FETNIM: A Potential Hypoxia Marker for PET , 2001 .
[22] M J Welch,et al. Evaluation of 64Cu-ATSM in vitro and in vivo in a hypoxic tumor model. , 1999, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[23] S M Bentzen,et al. Measurement of human tumour oxygenation status by a polarographic needle electrode. An analysis of inter- and intratumour heterogeneity. , 1994, Acta oncologica.
[24] J. D. Chapman,et al. Intracellular localization of radioactively labeled misonidazole in EMT-6-tumor cells in vitro. , 1982, International journal of radiation oncology, biology, physics.
[25] C. Stobbe,et al. Preclinical assessment of hypoxic marker specificity and sensitivity. , 1998, International journal of radiation oncology, biology, physics.
[26] David J. Schlyer,et al. Graphical Analysis of Reversible Radioligand Binding from Time—Activity Measurements Applied to [N-11C-Methyl]-(−)-Cocaine PET Studies in Human Subjects , 1990, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.